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Abstract: A personal selection of 32 recent papers is presented covering various 
aspects of current developments in bioorganic chemistry and novel natural products 
such as furanmonogone A from Hypericum monogynum.  
 
The structure of lecanicillolide 1, a metabolite of Lecanicillium sp. PR-M-3, was 
established by X-ray analysis.1 A biosynthetic pathway to lecanicillolide 1, involving 
two polyketide chains, has been proposed. The structure of phomone B 2, a racemic 
metabolite of Phoma sp. YN02-P-3, was also established by X-ray analysis.2 
Phomone B 2 is a dimer of the co-metabolite rosellin 3. Monascustin 4 has been 
isolated from Monascus purpureus fermented rice.3 It has been proposed that 
monascustin 4 is formed from lysine and acetoacetate precursors. Dahurelmusin A 5, 
from Elymus dahuricus infected by Epichloë bromicola, is also a hybrid peptide-
polyketide.4 The structures of monascustin 4 and dahurelmusin A 5 were confirmed 
by X-ray analyses. 
 
 The rearranged prenylated acylphloroglucinol furanmonogone A 6 has been isolated 
from flowers of Hypericum monogynum.5 A biosynthetic pathway to furanmonogone 
A 6 has been proposed involving an oxidative cleavage of the phloroglucinol ring. 
The fungus Biscogniauxia sp. 71-10-1-1, isolated from the lichen Usnea mutabilis, 
produces several metabolites including dimericbiscognienyne A 7 and its monomeric 
precursor biscognienyne B 8.6 Possible biosynthetic pathways to these metabolites 
have been presented. Pygmanilines A 9 and B 10 have been identified in the lichen 
Lichina pygmaea.7 The structures of these unusual aryl urea derivatives were 
confirmed by synthesis. 
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Penicisulfuranols A-F (e.g. A 11) are unusual epipolythiodioxopiperazine alkaloids, 
from Penicillium janthinellum, that have sulfur atoms on α- and β-positions of the 
amino acid residues rather than both on α-carbons.8 Several highly modified 
dioxopiperazine alkaloids, including versicoamide F 12, have been isolated from 
Aspergillus tennesseensis.9 The structure of versicoamide F 12 was confirmed by X-
ray analysis and biosynthetic pathways to this group of metabolites have been 
proposed. The novel spiro framework of macleayine 13, from Macleaya cordata, is 
proposed to be formed by cleavage of a protoberberine alkaloid precursor.10 It is 
suggested that the β-lactam ring of sophaline A 14, from seeds of Sophora 
alopecuroides, is formed by ring contraction of matrine.11 Pyrazolofluostatin A 15, a 
metabolite of marine-derived Micromonospora rosaria, contains an unusal pyrazole 
ring.12 The structures of both sophaline A 14 and pyrazolofluostatin A 15 were 
confirmed by X-ray analyses. 
 
Ganotheaecolin A 16, from the fruiting bodies of Ganoderma theaecolum, has a novel 
rearranged ergostane skeleton.13 Phomopsterone A 17, a metabolite of Phomospis sp. 
TJ507A, whose structure was confirmed by X-ray analysis, also has a novel 
rearranged ergostane skeleton.14 Biosynthetic pathways to both ganotheaecolin A 16 
and phomopsterone A 17 have been proposed. The limonoid dimer krishnadimer A 
18, from Xylocarpus moluccensis, shows non-biaryl axial chirality.15 The structure of 
krishnadimer A 18, including its P axial chirality, was established by X-ray analysis. 
A crystal structure was also used to confirm the structure of the dimeric abietane 
diterpenoid taxodikaloid A 19 from seeds of Taxodium ascendens.16 Taxodikaloid A 
19 has an oxazoline ring linking to two monomers. 
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A combination of heterologous expression and knockout bacteroid incubations has 
allowed the elucidation of genes associated with the bacterial biosynthesis of 
gibberellin A9 20.17 Assignment of the function of these genes has revealed that 
bacterial gibberellin biosynthesis is distinct to that found in plants and fungi. The 
characterisation of the biosynthetic gene cluster of ripostatin A 21, a polyketide 
antibiotic that inhibits RNA polymerase has been reported.18 This has led to an 
understanding of the origin of the phenyl acetic acid starter unit of ripostatin 
biosynthesis and its formation from phenylpyruvate via a one-carbon atom loss 
mediated by a phenylpyruvate dehydrogenase complex. 
 
The stereochemical course of the squalestatin tetraketide synthase (SQTKS) 
dehydratase (DH) domain involved in the formation of the C10 side-chain of 
squalestatin S1 22 has been described.19 Incubation of the DH domain with six 
potential diketide substrates showed that only (3R)-3-hydroxybutyryl and (2R,3R)-2-
methyl-3-hydroxybutyryl N-acetyl cysteamine thioesters were substrates and thus, 
demonstrates similar stereochemical preference as vertebrate fatty acid synthases. 
Further work in understanding the enzymes associated with the biosynthesis of the 
squalestatin S1 C10 side-chain has shown that the cis-acting enol reductase (ER) has 
broad substrate scope for diketides and triketides.20 A 3D model of ER based on these 
results suggests that after two rounds of the SQTKS, the ER sequesters its final 
substrate to prevent further chain extension. 
 
The one-pot synthesis of presteffimycinone 23, a biosynthetic intermediate of the 
anthracycline antibiotic steffimycin has been achieved through the combination of 
eight polyketide synthase enzymes and cyclases from three different type II 
polyketide synthase pathways.21 Engineered acyltransferase domains from 6-
deoxyerythronolide B biosynthesis, that have inverted extender unit specificity has 
been identified by direct screening of mutants from active site saturation libraries.22 
This approach led to the discovery of a set of mutants with dramatically altered 
selectivity, including a Tyr189Arg mutant that had preference for a non-natural 
alkyne-derived extender unit leading to the highly selective formation of 24. 
 
The structural elements that allow acinetobactin 25 to act as siderophore for the 
human pathogen Acinetobacter baumannii has been determined.23 The binding and 
cellular delivery of Fe(III) by acinetobactin and various analogues was evaluated and 
revealed that the hydroxamate moiety is essential for recognition by uptake 
machineries, while the imidazole unit may be a promising site for antibiotic 
conjugation. Feeding studies with deuterium and carbon-13 labelled glycerols have 
provided the first biosynthetic data of the antibiotic nucleocidin 26 in Streptomyces 
calvus.24 The presence of only a single deuterium atom from [2H5]-and (R)-[2H5]-
glycerol at the C-5’ of nucleocidin suggests that oxidation of this position occurs after 
ribose ring assembly and before or during introduction of the fluorine atom. 
 
Functional characterisation of the biosynthetic pathway of ketomemicins (e.g. 
ketomemicin B3 27), carbonylmethylene-containing pseudotripeptides has been 
reported.25 Malonyl-CoA and phenylpyruvate were found to be starter units and are 
combined using an aldolase dehydratase. A PLP-dependent glycine-C-
acetyltransferase then mediates a Claisen-type condensation between L-phenylalanine 
and benzylfumaryl-CoA, forming the pseudodipeptide unit. Mutants of a thermally 
stable cytochrome P450 enzyme (CYP119) from Sulfolobus solfataricus that contain 
an iridium porphyrin cofactor, can catalyse enantioselective intramolecular C-H bond 
amination of sulfonyl azides.26 The reactions proceed with high chemoselectivity of 
nitrene insertion into C-H bonds over reduction of the azides, forming 
enantioenriched sultams in high yields (Scheme 1). 
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A one-pot sustainable synthesis of pyrroles from diallylamines has been achieved 
using a chemoenzymatic metathesis-aromatisation cascade process.27 Ring closing 
metathesis of the diallylamines using Grubbs 2nd generation catalyst gave 3-pyrrolines 
that were then converted to the pyrroles in good yields by a monoamine oxidase 
enzyme mediated oxidation-aromatisation reaction (Scheme 2). A solar energy driven 
enzyme-, photo- and organo-catalytic process has been used to convert butanol to 2-
ethylhexenal.28 Alcohol dehydrogenase (ADH) initially converted the butanol to 
butraldehyde, with a platinum-seeded cadmium sulfide photocatalyst (Pt@CdS) used 
to regenerate the NAD+ cofactor (Scheme 3). To preserve enzyme and photocatalyst 
stability, a β-alanine catalysed aldol condensation under mild aqueous conditions was 
then used for production of 2-ethylhexenal. 
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A one-pot tandem, asymmetric process that combines organo- and chemoenzymatic 
reactions has been developed for the enantioselective and diastereoselective synthesis 
of 1,3-diols.29 Conditions were optimised for the organocatalytic aldol reaction and 
alcohol dehydrogenase mediated ketone reduction that suppressed side-reactions, 
allowing elevated scale synthesis of the (1R,3S)-diol from 3-chlorobenzaldehyde 
(Scheme 4). Enzyme screening has identified a ketoreductase clone from 
Scheffersomyces stipitis CBS 6045 (SsCR) that can catalyse the asymmetric reduction 
of aromatic ketones.30 The transformation was compatible to scale-up, resulting in a 
highly efficient synthesis of (R)-2-chloro-1-(2,4-dichlorophenyl)ethanol, a key 
synthetic intermediate for the preparation of various antifungal agents (Scheme 5). 
 
Various chemoenzymatic transformations have been evaluated for the asymmetric 
synthesis of the heart-rate reducing agent ivabradine 28.31 For example, the use of 
dynamic kinetic resolution of a racemic aldehyde precursor by asymmetric 
bioamination allowed the high yielding synthesis of the corresponding amine with 
excellent enantiopurity (Scheme 6). This was converted to ivabradine in a four-step 
sequence, in 50% overall yield and without the need of chromatographic purification. 
A one-pot, three-step asymmetric synthesis of (3R,3aS,6aR)-hexahydrofuro[2,3-
b]furan-3-ol, a key synthetic intermediate of various HIV protease inhibitors, 
including the drug darunavir has been developed using furan and a protected glycol 
aldehyde as starting materials.32 A [2+2]-photocycloaddition was followed by 
hydrogenation to give the deprotected oxetane (Scheme 7). Spontaneous 
rearrangement under thermodynamic control and kinetic resolution of the resulting 
racemic furanol with a lipase gave the key building block in high yield and excellent 
enantioselectivity. 
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